REGULATED PRESS RELEASE published on 10/19/2026 at 18:00, 9 days 13 hours ago L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola bioMérieux obtient une autorisation d'utilisation d'urgence du test BIOFIRE® Global Fever Special Pathogens de l'OMS dans la lutte contre l'épidémie d'Ebola BioMérieux OMS Autorisation D'urgence Test BIOFIRE Épidémie Ebola
PRESS RELEASE published on 10/19/2026 at 18:00, 9 days 13 hours ago Déclaration des transactions sur actions propres Le Groupe Vente-unique.com déclare les rachats d'actions propres conformément au règlement Abus de marché (MAR). Prochain rendez-vous : chiffre d'affaires 2025-2026 le 12 novembre 2026 Chiffre D'affaires MAR Rachats D'actions Vente-unique.com Home & Living
PRESS RELEASE published on 10/19/2026 at 18:00, 9 days 13 hours ago Disclosure of trading in own shares Vente-unique.com Group buys back own shares according to Market Abuse Regulation. Leading Home & Living platform in Europe. Visit bourse.vente-unique.com for more Shares Market Abuse Regulation Europe Vente-unique.com Home & Living
REGULATED PRESS RELEASE published on 10/19/2026 at 18:00, 9 days 13 hours ago OPmobility expands in Morocco with a new Exterior body parts production plant in Kenitra OPmobility expands in Morocco with a new exterior body parts production plant in Kenitra, further strengthening its industrial footprint in the country Automotive Industry Manufacturing Plant OPmobility Morocco Kénitra
REGULATED PRESS RELEASE published on 10/19/2026 at 18:00, 9 days 13 hours ago OPmobility poursuit son expansion au Maroc avec une nouvelle usine de production de pièces extérieures de carrosserie à Kénitra OPmobility inaugure une nouvelle usine de production de pièces extérieures de carrosserie à Kénitra, renforçant son engagement et contribuant au développement de l'industrie automobile au Maroc OPmobility Maroc Usine De Production Kénitra Pièces Carrosserie
PRESS RELEASE published on 10/19/2026 at 17:50, 9 days 13 hours ago VINCI: Disclosure of transactions on shares from October 12, 2026, to October 16, 2026 VINCI SA discloses transactions on shares from October 12 to October 16, 2026, in compliance with share buyback regulations. Details available on VINCI website Transactions Shares Share Buybacks Regulations VINCI SA
PRESS RELEASE published on 10/19/2026 at 17:50, 9 days 13 hours ago VINCI : Déclaration des transactions sur actions propres du 12 octobre au 16 octobre 2026 VINCI SA déclare les achats d'actions propres du 12 au 16 octobre 2026, conformément à la réglementation. Détails et informations disponibles sur le site internet de l'émetteur Rachat D'actions Transactions Achats D'actions Autorisation VINCI SA
PRESS RELEASE published on 10/19/2026 at 17:47, 9 days 13 hours ago IQLOOP Group Reports Türkiye Completes 455,357 Housing and Commercial Units in Post-Earthquake Reconstruction Program Istanbul, Turkey, October 19th, 2026, FinanceWire
PRESS RELEASE published on 10/19/2026 at 17:46, 9 days 13 hours ago VALBIOTIS SA: Valbiotis doublement récompensé « Meilleur Produit Pharma 2027 » pour ses solutions ValbiotisPRO® Cholestérol et ValbiotisPRO® Santé Métabolique Valbiotis doublement récompensé 'Meilleur Produit Pharma 2027' pour ses solutions ValbiotisPRO Cholestérol et ValbiotisPRO Santé Métabolique. Reconnaissance de 10 ans de R&D et innovations brevetées Innovation Recherche Et Développement Valbiotis Santé Cardiométabolique Meilleur Produit Pharma 2027
PRESS RELEASE published on 10/19/2026 at 17:46, 9 days 13 hours ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions Valbiotis receives double 'Best Pharma Product 2027' award for ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique. Recognition of ten years of research and development with patented active substances Valbiotis Metabolic Health Cholestérol Best Pharma Product 2027 French Pharmacy Market
Published on 10/28/2026 at 22:35, 8 hours 27 minutes ago Route1 Announces Third Quarter and Year to Date 2026 Financial Results Notification
Published on 10/28/2026 at 12:30, 18 hours 32 minutes ago Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 18 hours 32 minutes ago AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 18 hours 32 minutes ago Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out
Published on 10/28/2026 at 12:30, 18 hours 32 minutes ago Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq
Published on 10/29/2026 at 06:55, 7 minutes ago Pepperstone and Aston Martin Aramco extend and expand partnership with Fernando Alonso appointed Global Ambassador from 2027.
Published on 10/29/2026 at 06:55, 7 minutes ago Alzchem increases sales and profitability in the first nine months of 2026
Published on 10/29/2026 at 06:51, 11 minutes ago KION grows revenue and profitability in the first nine months driven by Intelligent Automation Solutions
Published on 10/29/2026 at 06:30, 31 minutes ago Redcare Pharmacy delivers strong Q3, with revenue increasing 18% driven by Rx and adjusted EBITDA margin up 1.0pp YoY to 3.4%.
Published on 10/29/2026 at 06:30, 31 minutes ago Ad hoc announcement pursuant to Art. 53 LR News Release
Published on 10/28/2026 at 17:56, 13 hours 6 minutes ago OPR - Mise à disposition de l'addendum au rapport d'expertise indépendante